Smokeless Cigarettes Market Growth With Worldwide Industry Analysis To 2030: Grand View Research Inc.

 Smokeless Cigarettes Market Growth & Trends 

The global smokeless cigarettes market size is expected to reach USD 93.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.0% from 2022 to 2030. The growing concerns over the harmful effect of tobacco-based cigarettes among various age groups have increased the demand for relatively less-toxic e-cigarettes and vape products, which is expected to bolster the market growth. According to an article published in BMJ Journal in 2019, approximately 20.8% of U.S. youth and 4.5% of U.S. adults are current e-cigarette users.

Furthermore, COVID-19-based marketing and digital sales strategies post-pandemic is also expected to support the market growth. According to an article published in Campaign for Tobacco-Free Kids, in May 2020, various e-cigarettes maker and vape shops promoted their products by offering free giveaways such as protective masks and 19% off nicotine e-liquids by entering the code COVID-19. Therefore, over the forecast period, the use of vape devices is expected to increase, especially among recreational smokers and smokers working to stop smoking altogether.

The electric segment was the largest revenue-generating segment in 2021 and is expected to maintain dominance in the forecast period. The increasing adoption of trendy lifestyles among consumers has led to the growth of smokeless cigarettes and other related products and forms. According to an article published in KPI6, in July 2021, approximately 64% of men are primarily involved in the conversation about e-cigarettes and vaping. Another key factor contributing to the rapid growth of e-cigarettes is the consumer shift from nicotine-based products to smoke-free cigarettes, which is expected to accelerate the market growth.

The offline distribution channel dominated the market in 2021. The convenient shopping experience of having various products, forms, and flavors of e-cigarettes in a single place is the primary driver for consumers to visit their nearby stores including supermarkets, hypermarkets, convenience stores, and others. Furthermore, the allowance of consumers to first check and then buy these devices through the above-mentioned stores will help the segment adapt well to the market growth.

Major players in the market include a combination of a few established players and many small players. Some of these are JUUL Labs Inc, British American Tobacco Plc, RELX Technology Co Ltd, Imperial Brands Plc, Japan Tobacco Inc, Shenzhen Joye Technology Co Ltd, Shenzhen IVPS Technology Co Ltd, Shenzhen Kanger Technology Co Ltd, Shenzhen Eigate Technology Co Ltd, Flavourart srl. Key players in this market face intense competition from each other as some of them are among the top manufacturers and have a large customer base for their products in both regional and international markets. 

Request a free sample copy or view the report summary: Smokeless Cigarettes Market Report

Smokeless Cigarettes Market Report Highlights

• North America dominated the market and accounted for the largest revenue share in 2021. The increasing launches of flavored cigarettes in the U.S. will support the market in the region
• The electric segment is projected to register faster growth during the forecast period as these products have advanced and programmable functions, such as temperature control
• The online segment is predicted to become the fastest growing segment during the forecast period owing to easy doorstep delivery services

Access Press Release@ https://www.grandviewresearch.com/press-release/global-smokeless-cigarettes-market

Smokeless Cigarettes Market Segmentation

Grand View Research has segmented the global smokeless cigarettes market based on product, distribution channel, and region:

Smokeless Cigarettes Product Outlook (Revenue, USD Million, 2017 - 2030)

• Non-electric
• Electric

Smokeless Cigarettes Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Offline
• Online

Smokeless Cigarettes Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • New Zealand
  • Philippines
• Central & South America
• Middle East & Africa
  • UAE
  • South Africa

List of Key Players in Smokeless Cigarettes Market

• JUUL Labs Inc.
• British American Tobacco Plc
• RELX Technology Co Ltd.
• Imperial Brands Plc
• Japan Tobacco Inc.
• Shenzhen Joye Technology Co. Ltd.
• Shenzhen IVPS Technology Co. Ltd.
• Shenzhen Kanger Technology Co. Ltd.
• Shenzhen Eigate Technology Co. Ltd.
• Flavourart Srl

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biopharmaceutical Third-party Logistics Market Trends Analysis And Forecast Till 2030: Grand View Research Inc.

 Biopharmaceutical Third-party Logistics Market Growth & Trends

The global biopharmaceutical third-party logistics market size is expected to reach USD 198.5 billion by 2030, growing at a CAGR of 5.9% over the forecast period, according to a new report by Grand View Research, Inc. The rising demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the biopharmaceutical third-party logistics (3PL) market growth. The rising adoption of automated storage and retrieval systems in emerging countries is an ongoing trend in the pharmaceutical logistics companies that have gained significant traction. The key market players played a vital role in the fight against COVID-19 by minimizing supply disruptions and prioritizing critical care drugs.

A sudden surge in the demand for cold chain logistics was observed during the pandemic because of the manufacturing and distribution of COVID-19 vaccines. The future also seems good for the global market with the rising demand for domestic logistics coupled with favorable government initiatives and policies. Furthermore, the trend of shifting from small molecule drugs to biopharmaceuticals, mainly vaccines, and biologics, is projected to drive the market. Since these small molecule drugs are temperature-sensitive products, demand for temperature-controlled transportation and storage increases and thus is responsible for the market growth.

Moreover, environmental concerns and costs have caused a slight shift in the means of transport used for commercial products, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck). Intermodal transport is majorly used by these pharmaceutical companies to reduce their carbon footprint. The ongoing trend shows that pharmaceutical manufacturers have shifted towards sea freight to reduce the cost and risk factors. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Request a free sample copy or view the report summary: Biopharmaceutical Third-party Logistics Market Report

Biopharmaceutical Third-party Logistics Market Report Highlights

• In 2021, the non-cold chain segment held the largest revenue share owing to the sales of a large number of drugs that do not require any temperature control
• The cold chain logistics segment is expected to register the fastest CAGR over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
• The warehousing and storage service types segment accounted for the largest market share in 2021
• Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period
• This is mainly attributed to the rising demand for medicines from the aging population and the shift of drug sales from brand manufacturers to generic

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopharmaceutical-third-party-logistics-3pl-market

Biopharmaceutical Third-party Logistics Market Segmentation

Grand View Research has segmented the global biopharmaceutical third-party logistics market based on the supply chain, service type, and region:

Biopharmaceutical 3PL Supply Chain Outlook (Revenue, USD Billion, 2018 - 2030)

• Cold Chain
• Non-cold Chain

Biopharmaceutical 3PL Service Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Transportation
  • Air Freight
  • Sea Freight
  • Overland
• Warehousing & Storage
• Others Services

Biopharmaceutical 3PL Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Biopharmaceutical Third-party Logistics Market

• FedEx
• DHL International GmbH
• SF Express
• United Parcel Service of America, Inc.
• AmerisourceBergen Corp.
• DB Schenker
• KUEHNE + NAGEL
• Kerry Logistics Network Ltd.
• Agility

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America, Europe & Asia Pacific Legal Cannabis Market Expected To Propel Industry Growth By 2030: Grand View Research Inc.

 North America, Europe & Asia Pacific Legal Cannabis Market Growth & Trends

The North America, Europe, and Asia Pacific legal cannabis market size is expected to reach USD 89.9 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 25.3% from 2022 to 2030. As more individuals become aware of the medical benefits of hemp, marijuana, and its derivatives, and as these products become more generally available, acceptance is expanding. Another key factor boosting market expansion is the increased acceptance of medicinal marijuana for the treatment of chronic diseases. Legalizing marijuana for adult use in many countries will assist in creating new job possibilities and add significantly to the economy. Tourism, real estate, finance, food, and transportation are just a few of the industries that will benefit from legalization. Manufacturers are facing challenges in setting up a functional and legalized channel for the development and trade of cannabis-derived products like cannabidiol due to the presence of strict laws.

The marijuana product segment led the market with a revenue share of over 70.0% in 2021. Marijuana for medical purposes is increasing in popularity as a result of recent legalizations in a number of nations. Patients with chronic diseases like Parkinson's disease, cancer, arthritis, Alzheimer's disease, and neurologic issues like depression, anxiety, and epilepsy are treated with marijuana. As a result, one of the primary reasons behind the expansion of this market is the widespread use of marijuana for the treatment of numerous chronic illnesses.

The CBD derivatives segment accounted for the largest revenue share in 2021 owing to the vast applications of these derivatives. It is extensively being used for medicinal purposes as well as for the cosmetic industry. In the APAC region, the cosmetic industry is a huge business and there has been a surge in the use of CBD derivatives in various skincare products. The others segment, being the fastest-growing category, is seeing an upward trend due to the increasing number of studies proving their prowess in the medical field.

The medical use segment emerged as the largest end-use segment in 2021. As medical cannabis is allowed in more countries than adult-use cannabis, the medical sector is likely to stay dominant during the forecast period. The increasing usage of cannabis and its derivatives in a variety of applications, including medicines, nutraceuticals, personal care and cosmetics, and edibles, is expected to increase the demand for these goods.

With a revenue share of over 80.0% in 2021, North America led the market. The availability of a large customer pool in the region and the early legalization of marijuana for medical and recreational use are major factors driving the market. Asia Pacific is predicted to be the fastest-growing market from 2022 to 2030 owing to the increased understanding of cannabis' medical and health benefits, which has prompted Asian countries to legalize cannabis and its derivatives.

During the pandemic, lockdowns and transit disruptions produced a disturbance in product supply, increasing the supply-demand disparity. As a result, the localized market and the worldwide market have been hampered. As customers gravitate away from traditional treatment approaches and move toward cannabis-based treatment, increased use of marijuana, largely for medicinal purposes, boosts the total market growth. Furthermore, the COVID-19 pandemic has significantly impacted the legal cannabis industry as a statewide lockdown has interrupted product production and imposed import/export restrictions, resulting in lower total revenue.

Request a free sample copy or view the report summary: North America, Europe & Asia Pacific Legal Cannabis Market Report

North America, Europe & Asia Pacific Legal Cannabis Market Report Highlights

• The market growth can be attributed to the greater use of hemp and marijuana products and increasing preference for medical marijuana. In addition, the upcoming legalization of marijuana for adult use is expected to boost growth over the predicted period
• Due to the increased acceptance of marijuana for various medical illnesses, marijuana emerged as the leading source type in 2021
• By end-use, the medical use segment held the largest revenue share in 2021. This is due to an increase in the product's use for chronic pain, mental illnesses such as anxiety, and sleep difficulties and increased knowledge among practitioners
• Owing to the increasing consumption rate as a result of legalization, North America accounted for the largest revenue share in 2021

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-europe-asia-pacific-legal-cannabis-market-analysis

North America, Europe & Asia Pacific Legal Cannabis Market Segmentation

Grand View Research, Inc. has segmented the North America, Europe, and Asia Pacific legal cannabis market based on source type, derivatives, end-use, and region:

North America, Europe & Asia Pacific Legal Cannabis End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Marijuana
  • Flower
  • Oil & Tinctures
• Hemp
  • Hemp CBD
  • Supplements
  • Industrial Hemp

North America, Europe & Asia Pacific Legal Cannabis Derivatives Outlook (Revenue, USD Million, 2017 - 2030)

• CBD
• THC
• Others

North America, Europe & Asia Pacific Legal Cannabis End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Medical Use
  • Cancer
  • Chronic Pain
  • Depression and Anxiety
  • Arthritis
  • Diabetes
  • Glaucoma
  • Migraines
  • Epilepsy
  • Multiple Sclerosis
  • AIDS
  • Amyotrophic Lateral Sclerosis
  • Alzheimer’s
  • Post-Traumatic Stress Disorder (PTSD)
  • Parkinson's
  • Tourette’s
  • Others
• Recreational Use
• Industrial Use
  • Textile
  • Non-textile

North America, Europe & Asia Pacific Legal Cannabis Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Czech Republic
  • Switzerland
• Asia Pacific
  • Australia
  • New Zealand
  • Thailand
  • Japan
  • South Korea

List of Key Players of North America, Europe & Asia Pacific Legal Cannabis Market

• CANOPY GROWTH CORPORATION
• Aurora Cannabis
• Tilray
• GW Pharmaceuticals, plc
• Organigram Holdings Inc
• Lexaria Bioscience Corp.
• VIVO Cannabis Inc.
• The Cronos Group
• AusCann Group Holdings Ltd.
• Cann Group Limited
• Bod Australia
• Zelira Therapeutics
• Althea Group
• THC Global Group Limited
• MGC Pharma
• ECOFIBRE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Breast Cancer Drug Market is Projected to Boost USD 38.4 Billion by 2025: Grand View Research Inc.

 The global breast cancer drug market size is expected to reach USD 38.4 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 10.7% during the forecast period. Early detection, increase in awareness, and incidence of breast cancer are some of the key trends stoking market growth.

Global breast cancer drugs market is expected to grow lucratively as many players focus majorly on R&D of innovative treatments. They engage in extensive research to develop novel drugs for the treatment of the disease to gain a higher market share. There exists a growing pressure and need for novel therapies and treatment due to rapidly accelerating prevalence of diseases. The strong pipeline is expected to provide new and effective treatment options and improved outcomes than existing therapies.

With advancements in drug delivery systems, various target specific therapies have been customized and designed as a carrier to infuse the therapeutic agent to the target site. Carriers for inducing target therapy include modified anticancer agent’s specific to molecular-recognition-element, anticancer peptides, and nanoparticle-based anticancer drugs. For instance, HER2/neu protein is usually given in combination with other anti-cancer drugs in targeted therapy.

1. Hoffman-La Roche Ltd leads the breast cancer drugs market with Herceptin, Perjeta, and Kadcyla. However, rapid advancements in biosimilarswith a goal to offer cost effective alternatives to patients is anticipated to put pressure on this space. For instance, in December 2017, the Food and Drug Administration (FDA) approved the first biosimilar of trastuzumab for HER2+ breast cancer.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/breast-cancer-drugs-market

Further key findings from the report suggest:

• HER2 inhibitors is expected to be the most preferred drug class segment over the forecast period, owing to their high specificity as they are subclass of target therapy
• CDK 4/6 inhibitor is expected to be the fastest growing segment over the forecast period. There are currently more than 45 CDK 4/6 inhibitor drug candidates in pipeline
• North America held the largest market share in 2017 owing to the factors such as the presence of key manufacturers in the country, high awareness and adoption, and well-established healthcare infrastructure among others
• Europe was estimated to be the second largest regional segment in 2017 due to increasing incidence of breast cancer and growing R&D investments
• Asia Pacific is anticipated to witness healthy growth over the next decade due to increasing incidence of breast cancer, rise in awareness about early diagnosis in emerging countries such as China and India.
• Companies such as F. Hoffmann-La Roche Ltd; Pfizer Inc.; AstraZeneca; Novartis AG; Astellas Pharma Inc.; and Eli Lilly and Company dominated the breast cancer drugs market
• The market is lucrative and competitive in nature as manufacturers engage in new product development to increase their product penetration. Moreover, they are entering into collaborations and partnerships to enhance their product portfolio.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-breast-cancer-drugs-market

Grand View Research has segmented the global breast cancer drugs market on the basis of type and region:

Breast Cancer Drug Type Outlook (Revenue, USD Million, 2014 - 2025)

• HER2 Inhibitors
• Mitotic Inhibitors
• Anti-metabolites
• Aromatase Inhibitors
• CDK 4/6 Inhibitors
• Hormonal Receptor

Breast Cancer Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Silicone Elastomers Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 Silicone Elastomers Market Growth & Trends

The global silicone elastomers market size is expected to reach USD 12.5 billion by 2030, according to a new study by Grand View Research, Inc. The market is projected to advance at a CAGR of 10.3% from 2022 to 2030. The growing population, rising disposable income, and rapid industrialization and urbanization in the developing regions are some of the key factors that are presumed to drive the regional markets. R&D initiatives to develop superior-quality robust products that have a wide application base across diverse industries offer ample opportunities for market development.

A surge in demand for properties such as extended lifetime, efficient performance over a wide range of temperatures, low toxicity, low flammability, low smoke density, inertness to chemicals & solvents, oil & fuel resistance, and high productivity is anticipated to be beneficial for the overall market advancement. The increasing scope of silicone elastomers in the healthcare industry is expected to have a positive impact on the market.

Some of the notable applications of silicone elastomers in the medical industry include catheters, tubing, medical cables, seals & gaskets, membranes, O-rings, valves, respiratory care applications, anesthetic masks, medical instruments & equipment, and medical textile coatings. Such a wide range of applications is touted to create ample opportunities for the silicone elastomers industry in the coming years.

The market for silicone elastomers has been classified into three segments, on the basis of product, application, and region. Major silicone elastomer products include high-temperature vulcanize (HTV), room temperature vulcanize (RTV), and liquid silicone rubber (LSR). HTV has dominated the market demand in the last few years. Room temperature vulcanize is slated to witness the highest growth rate during the forecast period.

Some of the prominent applications of silicone elastomers include electrical & electronics, automotive & transportation, industrial machinery, consumer goods, and construction, among others. The construction application segment dominated the global market in 2021, ahead of the automotive, and electrical & electronics segments. Other applications such as medical & healthcare and cosmetics are anticipated to experience the highest CAGR during the forecast period.

Regionally, the market has been segmented into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. North America occupied a significant market share in the recent past. However, this region, along with Western Europe, is expected to lose substantial market share and witness sluggish growth in the next seven years. Emerging markets such as the Asia Pacific are touted to witness the highest demand in the near future. Economies such as China, India, and Southeast Asian countries are projected to lead the regional market.

Request a free sample copy or view report summary: Silicone Elastomers Market Report

Silicone Elastomers Market Report Highlights

• Asia Pacific dominated the overall market and is expected to advance at the fastest CAGR of 10.6% in terms of revenue during the forecast period
• LSR was estimated to be the largest product segment in the global market for silicone elastomers in 2021 and is also anticipated to dominate the market during the projection period
• Construction accounted for the largest revenue share of more than 43% in the application segment of the global market for silicone elastomers in 2021 and is also anticipated to dominate the market in the projection period
• Silicone elastomers have widespread applications in the medical and healthcare industry. Starting from medical equipment to drug delivery systems, silicone elastomers have gained acceptance in this industry fairly rapidly. Such acceptance can be attributed to favorable properties such as inertness, high permeability, easy processing, and low toxicity

Access Press Release@ https://www.grandviewresearch.com/press-release/global-silicone-elastomers-market

Silicone Elastomers Market Segmentation

Grand View Research has segmented the global silicone elastomers market on the basis of product, application, and region:

Product Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• HTV
• RTV
• LSR

Application Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Electrical & Electronics
• Automotive & Transportation
• Industrial Machinery
• Consumer Goods
• Construction
• Others

Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• North America
  • US.
• Europe
  • Germany
  • France
  • UK
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players in the Silicone Elastomers Market

• China National BlueStar (Group) Co., Ltd.
• Dow Corning Corporation
• KCC Corporation
• Mesgo S.P.A.
• Momentive Performance Materials Inc.
• Shin-Etsu Chemical Co., Ltd.
• Reiss Manufacturing Inc.
• Wacker Chemie AG
• Zhejiang Xinan Chemical Industrial Group Co., Ltd.
• Stockwell Elastomerics
• Specialty Silicone Products, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Small Cell 5G Network Market Get Facts About Business Strategies 2020 to 2027: Grand View Research Inc.

 Small Cell 5G Network Market Growth & Trends

The global small cell 5G network market size is estimated to reach USD 28,476.4 million by 2027, registering a CAGR of 77.6% from 2020 to 2027, according to a new study by Grand View Research, Inc. The market attained a volume of 215 thousand units in 2019. Significant growth in the global mobile network traffic due to the massive adoption of smartphones across the globe has raised the rapid demand for high-speed data bandwidth among consumers. To deliver uninterrupted enhanced internet connectivity to consumers, Communication Service Providers (CSP) must opt for network densification and low-cost network solutions. This, in turn, is estimated to fuel the deployment of small cell 5G networks globally over the forecast period.

Significantly growing demand for high bandwidth capacity across a wide range of use cases such as accessing Ultra-high Definition (UHD) videos, cloud-based AR/VR gaming, and continual HD video meetings are expected to drive adoption of small-cell 5G network during the forecast period. Besides, to cater to the robust demand for improving data coverage and capacity in several crowded public places such as stadiums, airports, and malls, the deployment of small cell 5G networks is expected to see considerable growth over the forecast period. Moreover, the rising trends for telemedicine, remote patient monitoring, and remote surgeries across key countries such as the U.S., China, the U.K., and Japan, have surged the demand for faster data bandwidth in a bid to deliver unified connectivity in such critical applications. Also, the massive investments by federal governments in deploying advanced technologies across healthcare facilities is further anticipated to boost the installation of small cell 5G network globally.

With the evolving trends of industry 4.0, key industry players across the globe invested a significant amount in deploying many Industrial Internet of Things (IIoT) devices such as collaborative robots, Automated Guided Vehicles (AGV), UHD wireless cameras, and sensor-enabled machines, among others in their facilities. This helps these organizations to enhance the overall operational efficiency and productivity in such a highly competitive environment. Therefore, to establish constant communication among these IIoT devices, it is estimated to augment the deployment of next-generation small cell networks for industrial applications from 2020 to 2027. Furthermore, growing investments in deploying lamp post small cell 5G networks to provide high-speed bandwidth connectivity for smart city applications is further expected to drive the global market growth.

The ongoing pandemic of COVID-19 has shown an adverse impact on the small cell 5G network market. This outbreak has declined in the global production and trades of 5G small cells. Also, federal governments across key countries such as the U.S., France, the U.K., and Australia have temporarily postponed the 5G spectrum auctions in their countries. The escalating trade war between the two largest economies like China and the U.S., along with a high backhaul and transport network deployment costs, is further estimated to impede the market growth over the forecast period.

Request a free sample copy or view report summary: Small Cell 5G Network Market Report

Small Cell 5G Network Market Report Highlights

• Asia Pacific captured the largest market share of more than 30% in 2019 and is estimated to grow at a CAGR of 72.8% from 2020 to 2027. The growth is attributed to the rapid investments in deploying 5G infrastructure by major telecom operators across key countries such as China, Japan, and South Korea
• The robust deployment of small cell 5G networks in homes and offices to leverage enhanced bandwidth capacity is expected to lead to the indoor segment growth from 2020 to 2027
• With huge investments by key players to deploy cloud-based RAN to reduce the overall infrastructure costs, the virtualized network architecture segment is anticipated to see massive growth over the forecast period
• With the rapidly growing deployment across several mass gathering places such as stadiums, malls, and airports, the commercial segment is expected to capture the largest market share from 2020 to 2027
• Key market players such as Ericsson and Nokia Corporation are actively focused on developing new 5G-based small cells to strengthen their product portfolios and their market presence across several geographies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-small-cell-5g-network-market

Small Cell 5G Network Market Segmentation

Grand View Research has segmented the global small cell 5G network market on the basis of component, network model, network architecture, deployment mode, frequency type, end-user, and region:

Small Cell 5G Network Component Outlook (Volume, Thousand Units; Revenue, USD Million, 2019 - 2027)

• Hardware
  • Picocell
  • Femtocell
  • Microcell
• Services
  • Consulting
  • Deployment & Integration
  • Training and Support & Maintenance

Small Cell 5G Network Model Outlook (Volume, Thousand Units; Revenue, USD Million, 2019 - 2027)

• Standalone
• Non-standalone

Small Cell 5G Network Architecture Outlook (Volume, Thousand Units; Revenue, USD Million, 2019 - 2027)

• Distributed
• Virtualized

Small Cell 5G Network Deployment Mode Outlook (Volume, Thousand Units; Revenue, USD Million, 2019 - 2027)

• Indoor
• Outdoor

Small Cell 5G Network Frequency Type Outlook (Volume, Thousand Units; Revenue, USD Million, 2019 - 2027)

• Sub-6 GHz
• mmWave
• Sub-6GHz + mmWave

Small Cell 5G Network End-user Outlook (Volume, Thousand Units; Revenue, USD Million, 2019 - 2027)

• Residential
• Commercial
  • Corporates/ Enterprises
  • Hospitals
  • Hotels & Restaurants
  • Malls/Shops
  • Stadiums
  • Others
• Industrial
  • Smart Manufacturing
  • Energy & Utility
  • Oil & Gas and Mining
• Smart City
• Transportation & Logistics
• Government & Defense
• Others

Small Cell 5G Network Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2019 - 2027)

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • Italy
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• South America
  • Brazil
• The Middle East & Africa (MEA)

List of Key Players of Small Cell 5G Network Market

• Huawei Technologies Co., Ltd.
• Samsung Electronics Co., Ltd.
• Nokia Corporation
• Telefonaktiebolaget LM Ericsson
• ZTE Corporation
• Fujitsu Limited
• CommScope Inc.
• Comba Telecom Systems Holdings Ltd.
• Altiostar
• Airspan Networks
• Ceragon
• Contela
• Corning
• Baicells Technologies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Mycoplasma Testing Market Outlook & Future Forecast Report Till 2027

 Mycoplasma Testing Market Growth & Trends

The global mycoplasma testing market size is expected to reach a value of USD 1.87 billion by 2027, expanding at a CAGR of 14.9%, according to a new report by Grand View Research, Inc. The demand for mycoplasma testing products is anticipated to rise in near future with growing R&D investments in the field of life sciences. Huge opportunities in the life sciences segment are spurring market growth. Rising investment in biotechnology and pharmaceutical industries with rising healthcare spending is expected to further fuel the growth.

Government initiatives in the form of awareness campaigns for chronic diseases, such as cancer are also encouraging research-based activities. The National Research Council’s Industrial Research and Assistance Program (NRC-IRAP) provides technological support to small and medium scale life science companies in Canada involved in product development and innovation. According to Saudi Arabia’s 2030 Vision, its government is promoting the growth of pharmaceutical industries due to the fact that only 30% of its medication requirements are produced locally. Such factors are expected to drive market growth.

Mycoplasma contamination of cell culture is a growing concern for most researchers for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are conducted, which is expected to increase the demand for the related products and hence, the market growth.

Request a free sample copy or view report summary: Mycoplasma Testing Market Report

Mycoplasma Testing Market Report Highlights

• In 2019, kits and reagents dominated the market and is also expected to showcase the highest CAGR over the forecast period, owing to its increasing usage in mycoplasma tests
• The Polymerase Chain Reaction (PCR) segment held the largest market share in 2019 owing to the delivery of fast and accurate results associated with this technology
• Cell line testing is anticipated to exhibit the highest CAGR over the forecast period due to the increased risk of cell line contamination
• In 2019, pharmaceutical and biotechnology companies accounted for the largest mycoplasma testing market share due to rising research activities in drug discovery and development
• North America dominated the market in 2019 owing to rising healthcare spending levels and government funding for life science-related research
• Asia Pacific is expected to expand at an exponential CAGR during the forecast period, attributed to an increase in healthcare spending along with rising in demand for better infrastructure in laboratory and clinical research
• Some of the key market players are Merck KGaA; Thermo Fisher Scientific; Lonza Group Ltd.; Charles River Laboratories International, Inc.; PromoCell GmbH; and Bionique Testing Laboratories, Inc.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mycoplasma-testing-market

Mycoplasma Testing Market Segmentation

Grand View Research has segmented the global mycoplasma testing market on the basis of product, technology, application, end-use, and region:

Mycoplasma Testing Product Outlook (Revenue, USD Million, 2016 - 2027)

• Instruments
• Kits & Reagents
  • PCR Assays
  • Nucleic Acid Detection Kits
  • Stains
  • Elimination Kits
  • Standards & Controls
  • Others
• Services

Mycoplasma Testing Technology Outlook (Revenue, USD Million, 2016 - 2027)

• PCR
• ELISA
• Direct Assay
• Indirect Assay
• Microbial Culture Techniques
• Enzymatic Methods

Mycoplasma Testing Application Outlook (Revenue, USD Million, 2016 - 2027)

• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others

Mycoplasma Testing End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Others

Mycoplasma Testing Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wood Pellet Market Top Players, Segments, Cost Structure, Demand, Sales | 2027 Forecast

 The global wood pellets market size is expected to reach USD 18.22 billion by 2027, exhibiting a revenue-based CAGR of 9.4% during the forecast period, according to a new report by Grand View Research, Inc. Wood pellets can be used as an alternative for fossil fuels as they are eco-friendly, sustainable, and carbon neutral in nature. This factor is anticipated to drive the growth of the market.

Rising demand from the power generation industry is likely to drive the market over the forecast period. In addition, increasing awareness regarding the use of renewable energy sources for power generation coupled with the high combustion of wood pellet is likely to augment the demand for wood pellets over the forecast period.

Rising concerns regarding global warming and climate change coupled with rising oil prices are expected to boost the demand for renewable energy. In addition, the increased government spending on the utilization of renewable energy for power generation is likely to augment the demand for wood pellets over the forecast period.

The market is characterized by the presence of large-scale manufacturers catering the global demand. The demand for wood pellet is high in developed economies including U.K., Germany, Netherlands, Italy, and U.S. owing to their increasing application for electricity generation in coal-fired power plants and domestic heating.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/wood-pellets-market

Further key findings from the report suggest:

• The power plants application segment is likely to register a CAGR of 7.4% in terms of revenue, over the forecast period
• Residential heating application held the leading wood pellets market share of 46.1% in 2019 owing to simple pellet heating technology coupled with minimum operation and maintenance requirements
• Commercial heating is expected to be fastest growing application segment exhibiting a CAGR of 11.8% by revenue owing to increasing use of wood pellets for the heating of federal or municipal buildings, office buildings, educational facilities, and other commercial buildings
• Europe accounted for the market share of 85.9% in 2019, owing to the high consumption of the product in U.K., Italy, Germany, Denmark, Sweden, France, and Belgium
• Key market players are undertaking mergers and collaborations to expand their reach and increase production capacity, thereby gaining greater market share

Access Press Release@ https://www.grandviewresearch.com/press-release/global-wood-pellets-market

Grand View Research has segmented the global wood pellets market on the basis of application and region:

Wood Pellets Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

• Power Plants
• Residential Heating
• Commercial Heating
• Combined Heat and Power (CHP)

Wood Pellets Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • Egypt

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Non-alcoholic Beverages Market Plying for Significant Growth During 2022-2030: Grand View Research Inc.

 Non-alcoholic Beverages Market Growth & Trends

The global non-alcoholic beverages market size is expected to reach USD 1,363.1 billion by 2030, expanding at a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc., owing to factors such as rising disposable income, population growth, and changing lifestyles. Increasing concerns regarding obesity and health awareness are expected to trigger the growth of low-sugar carbonated drinks, tea & coffee, and bottled water.

Brands globally have been innovating new products with new flavors and premium flavors in product categories, such as carbonated beverages, bottled water, and tea & coffee, which would further support the category growth. For instance, in May 2021, Danone S.A. launched the first flavored and sparkling line from its Evian bottled water brand in the U.S., available in four flavors such as Raspberry & Ginseng, Lime & Ginger, Grapefruit & Basil, and Cucumber & Mint.

In terms of product, the bottled water segment is expected to be the fastest-growing segment during the forecast period. Product launches in this segment by key players in the market are likely to supplement the overall segment growth. For instance, in July 2020, Dutch-based brand Bottle Up launched its product offering in the U.K. with its pre-filled, reusable, BPA-free, and plant-based water bottles. The bottles would be available in 438 WHSmith locations across U.K., including the train station and airport locations, such as Manchester Piccadilly, Euston, Heathrow, Luton, Waterloo, Victoria, and several hospitals.

The retail distribution channels held the largest share in 2021 and are expected to remain dominant during the forecast period. The rise in demand for non-alcoholic beverages or zero-alcohol drinks by the consumers has made these retailers hold a larger share of such products by different brands such as Welch, Budweiser, Busch, and Great Value, especially in supermarkets such as Aldi, Whole Foods, and Walmart.

The non-alcoholic beverages market is consolidated in nature with the presence of a large number of international players and few regional players. Nestlé, PepsiCo, Unilever, Keurig Dr Pepper Inc., The Coca-Cola Company, Cott Corporation, Danone S.A., SUNTORY BEVERAGE & FOOD LIMITED, Asahi Group Holdings, Ltd., and Red Bull are among the prominent players in the global market.

Request a free sample copy or view report summary: Non-alcoholic Beverages Market Report

Non-Alcoholic Beverages Market Report Highlights

• Asia Pacific is expected to contribute a majority of the share to become the largest division in the global revenue in 2021. The preference for healthier non-alcoholic beverages among consumers is increasing the demand for such beverages in the region
• The bottled water segment is projected to register the fastest growth during the forecast period from 2022 to 2030
• The retail distribution channel segment is expected to register faster growth during the forecast period. An increase in product availability by various brands in the hypermarkets, and supermarkets coupled with the increase in internet penetration is likely to bode well with the future segment growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-nonalcoholic-beverage-market

Non-alcoholic Beverages Market Segmentation

Grand View Research has segmented the non-alcoholic beverages market based on product, distribution channel, and region:

Product Outlook (Revenue, USD Billion, 2017 - 2030)

• Carbonated Soft Drinks
• Bottled Water
• Tea & Coffee
• Juices
• Others

Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Food Service
• Retail
  • Hypermarkets & Supermarkets
  • Online
  • Others

Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • Japan
  • India
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Non-alcoholic Beverages Market

• Nestlé
• PepsiCo
• Unilever
• Keurig Dr Pepper Inc.
• The Coca-Cola Company
• Cott Corporation
• Danone S.A.
• SUNTORY BEVERAGE & FOOD LIMITED
• Asahi Group Holdings, Ltd.
• Red Bull

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Demand for Liquid Biopsy Market Increasing in Most Part of World 2028

 Liquid Biopsy Market Growth & Trends

The global liquid biopsy market size is expected to reach USD 19.35 billion by 2028, registering a CAGR of 13.5% during the forecast period, according to a new report by Grand View Research, Inc. It is a revolutionary technique that has created various opportunities that were previously unexplored.

It aids in the detection and isolation of circulating tumor DNA, exosomes, and circulating tumor cells and is a source of proteomics and genomics information in cancer patients. Rapid development in digital Polymerase Chain Reaction (PCR) and NGS-based technology has improved the accuracy of liquid biopsy. It can be performed repeatedly for disease monitoring and is anticipated to help overcome the limitations of tissue biopsies.

As liquid biopsies are the most promising novel techniques for cancer care, established as well as emerging companies have increased their R&D to develop novel liquid biopsy solutions. For instance, in September 2021, AnchorDx Medical Co., Ltd.; a China-based developer of early cancer detection and oncology screening solutions developed a diagnostic model for early breast cancer detection. The model is based on the methylation patterns of cfDNA.

Request a free sample copy or view report summary: Liquid Biopsy Market Report

Liquid Biopsy Market Report Highlights

• The Multi-gene Parallel Analysis (NGS) technology segment held the largest revenue share of the global market in 2020
• This can be attributed to rapid enhancements in NGS technology. With this technology, liquid biopsies are anticipated to gain considerable importance in cancer-related studies and research
• On the basis of sample type, blood sample-based tests dominated the market in 2020
• Blood samples can readily be taken at a more frequent interval, thus increasing the adoption rate
• Circulating Nucleic Acids are the most commonly used biomarker for liquid biopsy tests
• The factors, such as the constantly evolving pipeline of ctDNA-based liquid biopsy tests, an increasing number of commercialized products, and the potential of ctRNA in determining molecular profile have contributed to the dominance of this segment
• North America is expected to be the largest revenue-generating region by 2028 owing to a high incidence of cancer, rapid technological advancements, and the presence of key players in the region
• Key players are focused on business expansion through product launches, mergers & acquisitions, agreements, partnerships, and other growth strategies
• For instance, in June 2021, Biocept, Inc. collaborated with Quest Diagnostics to provide advanced NGS-based liquid biopsy testing for lung cancer patients

Access Press Release@ https://www.grandviewresearch.com/press-release/liquid-biopsy-market

Liquid Biopsy Market Segmentation

Grand View Research has segmented the global liquid biopsy market on the basis of sample type, biomarker, technology, and region:

Liquid Biopsy Sample Type Outlook (Revenue, USD Million, 2017 - 2028)

• Blood Sample Based
• Others

Liquid Biopsy Biomarker Outlook (Revenue, USD Million, 2017 - 2028)

• Circulating Nucleic Acids
• CTC
• Exosomes/Microvesicles
• Circulating Proteins

Liquid Biopsy Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Multi-gene-parallel Analysis (NGS)
• Single Gene Analysis (PCR Microarrays)

Liquid Biopsy Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

List of Key Players of Liquid Biopsy Market

• QIAGEN
• Myriad Genetics, Inc.
• BIOCEPT, Inc.
• Guardant Health, Inc.
• Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Angle plc
• Oncimmune
• Thermo Fisher Scientific, Inc.
• Lucence health Inc.
• Freenome holdings, Inc.
• EPIGENOMICS AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.